Antiviral Susceptibilities of Distinct Lineages of Influenza C and D Viruses

• Published in: Viruses Vol. 15; no. 1; p. 244
• Main Authors: Takashita, Emi, Murakami, Shin, Matsuzaki, Yoko, Fujisaki, Seiichiro, Morita, Hiroko, Nagata, Shiho, Katayama, Misa, Mizuta, Katsumi, Nishimura, Hidekazu, Watanabe, Shinji, Horimoto, Taisuke, Hasegawa, Hideki
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 15.01.2023; MDPI
• Subjects: Amino acids; Antiviral agents; Antiviral Agents - pharmacology; Antiviral Agents - therapeutic use; Antiviral drugs; antiviral susceptibility; baloxavir; Brazil; Communication; DNA-directed RNA polymerase; Drug Resistance, Viral - genetics; favipiravir; Genetic analysis; Humans; Influenza; Influenza A; Influenza C; influenza C virus; influenza D virus; Influenza, Human - drug therapy; Life sciences; Mississippi; Monoclonal antibodies; Orthomyxoviridae; Proteins; Public health; risk; RNA polymerase; RNA polymerase inhibitor; Severe acute respiratory syndrome coronavirus 2; Viruses; Brazil; Mississippi; United States > US; Japan; Oklahoma; Nebraska; influenza D virus; antiviral susceptibility; baloxavir; favipiravir; RNA polymerase inhibitor; influenza C virus
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v15010244

The emergence and spread of antiviral-resistant influenza viruses are of great concern. To minimize the public health risk, it is important to monitor antiviral susceptibilities of influenza viruses. Analyses of the antiviral susceptibilities of influenza A and B viruses have been conducted globally...